Maryann Redlinger
Maryann Redlinger publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Cancer therapeutics and mechanisms.
- World rank
- #2,251,702 of 7,710,434 ranked researchers
- Rank in United States
- #673,608 of 1,627,098
- Works
- 34
- Citations
- 1.8k
- Citations per work
- 53.9
What does Maryann Redlinger research?
Maryann Redlinger's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (26%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1852.0%
- Medicine1852.0%
- Life Sciences926.0%
- Everything else722.0%
- 1Oncology27% of their works
- 2Molecular Biology23% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Endocrinology, Diabetes and Metabolism6% of their works
- 5Epidemiology4% of their works
- 6Cancer Research3% of their works
Research topics
Which keywords describe Maryann Redlinger's research?
The keywords of their largest research topics: Chemotherapy, BRAF Mutation, Cetuximab, KRAS Mutations, Cancer, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and DNA.
- Disease
- Autophagy
- Thyroid Nodules
- Differentiated Thyroid Cancer
- Targeted Therapy
- DNA
- Chemotherapy-Induced Peripheral Neuropathy
- KRAS Mutations
- BRAF Mutation
- Chemotherapy
- Cetuximab
- Cancer
- Taxanes
- EGFR Mutations
- Topoisomerases
- Signaling
- mTOR
- BRAF gene
- MAP Kinase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Chemotherapy142 topics
- BRAF Mutation132 topics
- Cetuximab91 topic
- KRAS Mutations91 topic
- Cancer72 topics
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Taxanes61 topic
- DNA51 topic
- EGFR Mutations51 topic
- Targeted Therapy51 topic
- Topoisomerases51 topic
- Differentiated Thyroid Cancer41 topic
- Signaling41 topic
- Thyroid Nodules41 topic
- mTOR41 topic
- Autophagy31 topic
- BRAF gene31 topic
- Disease31 topic
- MAP Kinase31 topic
Where does Maryann Redlinger work?
Maryann Redlinger's main affiliation in the publication record is University of Pennsylvania, United States.
How many publications and citations does Maryann Redlinger have?
OpenAlex counts 34 works and 1,832 citations for Maryann Redlinger, an h-index of 14, ranking #2,251,702 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Maryann Redlinger. Posts are plain text and can be reported.